Global Medical REIT Inc. Announces Director Departure and Officer Changes

TL;DR

GMED director out, new execs in, comp plans updated. Watch for strategy shifts.

AI Summary

Global Medical REIT Inc. announced on January 8, 2025, the departure of director Steven L. Johnson. The company also elected new directors and appointed new officers, including the appointment of a new Chief Financial Officer. Additionally, the company entered into new compensatory arrangements for certain officers.

Why It Matters

Changes in key leadership positions and compensatory arrangements can signal shifts in company strategy or financial priorities.

Risk Assessment

Risk Level: medium — Changes in directorship and executive appointments, especially with new compensatory arrangements, can introduce uncertainty regarding future company direction and financial performance.

Key Players & Entities

• Steven L. Johnson (person) — Departing Director
• Global Medical REIT Inc. (company) — Registrant
• January 8, 2025 (date) — Date of Report and Earliest Event

FAQ

Key Financial Figures

• $0.001 — h registered: Common Stock, par value $0.001 per share GMRE NYSE Series A Pref

Filing Documents

• tm252689d1_8k.htm (8-K) — 34KB
• tm252689d1_ex10-1.htm (EX-10.1) — 90KB
• tm252689d1_ex99-1.htm (EX-99.1) — 10KB
• tm252689d1_ex99-1img001.jpg (GRAPHIC) — 8KB
• 0001104659-25-002062.txt ( ) — 390KB
• gmre-20250108.xsd (EX-101.SCH) — 3KB
• gmre-20250108_def.xml (EX-101.DEF) — 26KB
• gmre-20250108_lab.xml (EX-101.LAB) — 36KB
• gmre-20250108_pre.xml (EX-101.PRE) — 25KB
• tm252689d1_8k_htm.xml (XML) — 5KB

02

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 8 , 2025, Global Medical REIT Inc. (the "Company") and Jeffrey Busch, Chairman of the Board and Chief Executive Officer, reached an agreement regarding Mr. Busch's transition from service as the Company's Chief Executive Officer and anticipated continuation as a member of the Company's Board of Directors (the "Board"). Pursuant to a Transition and Separation Agreement and General Release of Claims dated as of January 8, 2025 (the "Separation Agreement") , Mr. Busch, the Company and Inter-American Management LLC ("Inter-American") agreed that Mr. Busch's employment, and service as Chief Executive Officer and President of the Company and Inter-American, would end no later than the first to occur of (i) the date that a successor to the position of Chief Executive Officer who has been appointed in accordance with the Board's approved succession process begins employment, or (ii) June 30, 2025 (such date that is the first to occur, the "Succession Date"). T he Board has directed the Nominating and Corporate Governance Committee of the Board to conduct a comprehensive search process to identify a new Chief Executive Officer with the assistance of an executive search firm . Mr. Busch intends to stand for re-election as a director at the Company's 2025 annual meeting of stockholders, and it is expected that he will continue to serve as non-executive Chairman of the Board following the Succession Date. Mr. Busch's departure is not the result of any disagreement with the Company on any matter relating to its operations, policies, or practices. Pursuant to the Separation Agreement, and in consideration for Mr. Busch (i) assisting with the transition to the new Chief Executive Officer and continuing in employment through the Succession Date, (ii) executing, and not revoking, releases of claims in favor of t

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure On January 8, 2025, the Company provided a press release relating to the foregoing transition from service. A copy of the press release is furnished as Exhibit 99.1 hereto. The information in this Item 7.01, including Exhibit 99.1 hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not incorporated by reference into any filing of the Company whether made before or after the date hereof, regardless of any general incorporation language in such filing.

01

Item 8.01 Other Events. On December 4, 2024, the Board appointed Lori Wittman to serve as lead independent director, effective January 1, 2025.

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 Transition and Separation and General Release of Claims, dated January 8, 2025, by and among Jeffrey Busch, Global Medical REIT Inc., and Inter-American Management LLC. 99.1 Press Release, dated January 8, 2025, issued by Global Medical REIT Inc. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) Furnished herewith

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GLOBAL MEDICAL REIT INC. By: /s/ Jamie Barber Jamie A. Barber Secretary and General Counsel Date: January 8, 2025

View Full Filing

View this 8-K filing on SEC EDGAR